LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 91 filers reported holding LEGEND BIOTECH CORP in Q3 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,951,143 | +105.3% | 356,575 | +111.0% | 0.01% | +100.0% |
Q2 2023 | $11,668,071 | +41.1% | 169,029 | -1.4% | 0.00% | +33.3% |
Q1 2023 | $8,268,091 | +50.5% | 171,466 | +55.8% | 0.00% | +50.0% |
Q4 2022 | $5,494,046 | +37.0% | 110,057 | +12.0% | 0.00% | 0.0% |
Q3 2022 | $4,010,000 | -17.6% | 98,291 | +11.0% | 0.00% | 0.0% |
Q2 2022 | $4,869,000 | +31.9% | 88,530 | -12.9% | 0.00% | +100.0% |
Q1 2022 | $3,692,000 | -22.6% | 101,595 | -0.8% | 0.00% | 0.0% |
Q4 2021 | $4,773,000 | +66.7% | 102,404 | +80.7% | 0.00% | 0.0% |
Q3 2021 | $2,864,000 | +2946.8% | 56,656 | +2374.1% | 0.00% | – |
Q2 2021 | $94,000 | +74.1% | 2,290 | +23.3% | 0.00% | – |
Q1 2021 | $54,000 | -1.8% | 1,857 | -5.7% | 0.00% | – |
Q4 2020 | $55,000 | +52.8% | 1,970 | +68.7% | 0.00% | – |
Q3 2020 | $36,000 | +71.4% | 1,168 | +133.6% | 0.00% | – |
Q2 2020 | $21,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |